Marie Goua

Dr. Marie Goua

Robert Gordon University, Aberdeen, UK
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
FPFranziska Pohl
Franziska Pohl
ATAndreia Teixeira-Castro
Andreia Teixeira-Castro
MCMarta Costa
Marta Costa
VLVictoria Lindsay
Victoria Lindsay
JFJuliana Fiúza-Fernandes
Juliana Fiúza-Fernandes
PLPaul Kong Thoo Lin
Paul Kong Thoo Lin
Genetic mutations and aging-associated oxidative damage underlie the onset and progression of neurodegenerative diseases, like Parkinson’s disease (PD) and Machado-Joseph disease (MJD). Natural products derived from plants have been regarded as important sources of novel bioactive compounds to counteract neurodegeneration. Here, we tested the neuroprotective effect of an ethanolic extract of rapeseed pomace (RSP), a rapeseed (canola) oil production by-product, in C. elegans models of MJD and PD. The extract, containing sinapine and other phenolics, restored motor function of mutant ataxin-3 (ATXN3) animals (MJD) and prevented degeneration of dopaminergic neurons in one toxin-induced and two genetic models of PD. Whole-organism sensors of antioxidant and xenobiotic response activation revealed the induction of phase II detoxification enzymes, including glutathione S- transferase (GST-4) upon RSP extract supplementation. Furthermore in vivo pharmacogenetic studies confirmed gst-4 is required for the therapeutic effect of RSP extract in the two disease models. The results suggest that GST-4-mediated antioxidant pathways may constitute promising therapeutic co-targets for neurodegenerative diseases and confirm the utility of searching for bioactive compounds in novel sources, including food and agricultural waste/by-products, such as RSP.

1 July 2007 in Atherosclerosis
Verified
Journal Article
Closed access
Roberta CazzolaRoberta Cazzola
Roberta Cazzola
SRSamantha Russo-Volpe
Samantha Russo-Volpe
EMElizabeth A Miles
Elizabeth A Miles
DRDinka Rees
Dinka Rees
TBTapati Banerjee
Tapati Banerjee
BCBenvenuto Cestaro
Benvenuto Cestaro

1 January 2008 in Prostaglandins, Leukotrienes and Essential Fatty Acids
Verified
Journal Article
Closed access
Marie GouaMarie Goua
Marie Goua
SMS. Mulgrew
S. Mulgrew
JFJ. Frank
J. Frank
DRD. Rees
D. Rees
ASA.A. Sneddon
A.A. Sneddon
KWK.W.J. Wahle
K.W.J. Wahle

26 June 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
HMHanna Mazur-Marzec
Hanna Mazur-Marzec
AFAnna Fidor
Anna Fidor
Marta Weronika CegłowskaMarta Weronika Cegłowska
Marta Weronika Cegłowska
Ewa WieczerzakEwa Wieczerzak
Ewa Wieczerzak
MKMagdalena Kropidłowska
Magdalena Kropidłowska
Christine EdwardsChristine Edwards
Christine Edwards
Cyanopeptolins (CPs) are one of the most frequently occurring cyanobacterial peptides, many of which are inhibitors of serine proteases. Some CP variants are also acutely toxic to aquatic organisms, especially small crustaceans. In this study, thirteen CPs, including twelve new variants, were detected in the cyanobacterium Nostoc edaphicum CCNP1411 isolated from the Gulf of Gdańsk (southern Baltic Sea). Structural elucidation was performed by tandem mass spectrometry with verification by NMR for CP962 and CP985. Trypsin and chymotrypsin inhibition assays confirmed the significance of the residue adjacent to 3-amino-6-hydroxy-2-piperidone (Ahp) for the activity of the peptides. Arginine-containing CPs (CPs-Arg2) inhibited trypsin at low IC50 values (0.24–0.26 µM) and showed mild activity against chymotrypsin (IC50 3.1–3.8 µM), while tyrosine-containing CPs (CPs-Tyr2) were selectively and potently active against chymotrypsin (IC50 0.26 µM). No degradation of the peptides was observed during the enzyme assays. Neither of the CPs were active against thrombin, elastase or protein phosphatase 1. Two CPs (CP962 and CP985) had no cytotoxic effects on MCF-7 breast cancer cells. Strong and selective activity of the new cyanopeptolin variants makes them potential candidates for the development of drugs against metabolic disorders and other diseases.

13 August 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
Garyfallia KapravelouGaryfallia Kapravelou
Garyfallia Kapravelou
RMRosario Martínez
Rosario Martínez
GPGloria Perazzoli
Gloria Perazzoli
Cristina Sánchez-GonzálezCristina Sánchez-González
Cristina Sánchez-González
Juan LlopisJuan Llopis
Juan Llopis
JPJesus Porres
Jesus Porres
The use of legumes as functional foods has gained increasing attention for the prevention and treatment of the so called non-communicable diseases that are highly prevalent worldwide. In this regard, biotechnological approaches for the enhancement of legumes’ nutritional and functional value have been extensively employed. In the present study, the process of germination increased several parameters of mung bean (Vigna radiata L.) functionality, including extract yield, total phenolic content and in vitro antioxidant capacity. In addition, 3-day-germinated mung bean proved to be an interesting source of dietary essential minerals and exhibited a greater variety of polyphenolic compounds compared to raw mung bean. These properties resulted in enhanced cytoprotective features of the 3-day mung bean extracts against radical oxygen species in human colorectal (HT29) and monocyte (U937) cell lines. Moreover, the antiproliferative effects were tested in different colon cancer cell lines, T84 and drug-resistant HCT-18, as well as in a non-tumor colon CCD-18 line. Altogether, our results demonstrate that the germination process improves the mung bean’s nutritional value and its potential as a functional food.

1 January 2018 in Food Chemistry
Verified
Journal Article
Closed access
FPFranziska Pohl
Franziska Pohl
Marie GouaMarie Goua
Marie Goua
GBGiovanna Bermano
Giovanna Bermano
WRWendy Russell
Wendy Russell
LSLorraine Scobbie
Lorraine Scobbie
PLPaul Kong Thoo Lin
Paul Kong Thoo Lin